Press release
Oncology Molecular Diagnostics Market to Grow at 6.2% CAGR, Reaching USD 6.46 Billion by 2033, Led by Roche, Abbott, and Qiagen | DataM Intelligence
Oncology Molecular Diagnostics Market
United States: Recent Industry Developments
✅ In October 2025, Roche Diagnostics launched a comprehensive liquid biopsy panel for early detection of 50 cancer types from a single blood draw.
✅ In October 2025, the FDA approved Foundation Medicine's new companion diagnostic for a novel targeted therapy in lung cancer.
✅ In October 2025, Guardant Health introduced an AI-powered platform for real-time monitoring of treatment response in metastatic cancers.
Japan: Recent Industry Developments
✅ In October 2025, Sysmex Corporation developed a novel circulating tumour DNA detection system with 99% specificity for early cancer screening.
✅ In October 2025, the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) fast-tracked approval for five new companion diagnostics.
✅ In October 2025, Miraca Holdings launched a nationwide molecular profiling program for personalised cancer treatment across 200 hospitals.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/oncology-molecular-diagnostics-market?jd
Market Trends & Drivers
The Oncology Molecular Diagnostics Market is experiencing rapid growth driven by increasing cancer prevalence, advancements in precision medicine, and rising adoption of companion diagnostics. Key trends include the shift towards liquid biopsy technologies, integration of artificial intelligence in data analysis, and development of multi-cancer early detection tests. The growing emphasis on personalized treatment, regulatory support for targeted therapies, and technological innovations in genomic sequencing are significantly accelerating market expansion.
Competitive Landscape
The market features intense competition among diagnostic companies, pharmaceutical partners, and technology innovators.
Roche Diagnostics leads with its cobas portfolio and comprehensive companion diagnostic solutions.
Abbott Laboratories dominates in PCR-based oncology testing and rapid diagnostic platforms.
Qiagen N.V. provides sample preparation technologies and bioinformatics solutions for molecular diagnostics.
Foundation Medicine, Inc. (Roche) specializes in comprehensive genomic profiling for cancer patients.
Guardant Health, Inc. pioneers liquid biopsy technology for cancer detection and monitoring.
Illumina, Inc. provides next-generation sequencing platforms for comprehensive genomic analysis.
Myriad Genetics, Inc. focuses on hereditary cancer testing and companion diagnostics.
Agilent Technologies, Inc. offers advanced instrumentation and reagents for molecular pathology.
Bio-Rad Laboratories, Inc. provides droplet digital PCR technology for sensitive mutation detection.
Thermo Fisher Scientific delivers comprehensive solutions from sample to answer in molecular diagnostics.
Segmentation
By Product Type [Reagents, Instruments, Software]
By Technology [Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization (ISH), Others]
By Application [Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Others]
By End-User [Hospitals, Clinical Laboratories, Others]
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/oncology-molecular-diagnostics-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, Switzerland, Rest of Europe)
⇥ Asia-Pacific (Japan, China, India, South Korea, Australia, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Colombia, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialise in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Molecular Diagnostics Market to Grow at 6.2% CAGR, Reaching USD 6.46 Billion by 2033, Led by Roche, Abbott, and Qiagen | DataM Intelligence here
News-ID: 4246597 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Clinical Trial Management System Market Set for Strong Growth to USD 4.2 Billion …
The Global Clinical Trial Management System Market reached USD 1.5 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global clinical trial management system market is expected to exhibit a CAGR of 14.6% during the forecast period (2024-2031).
Market growth is driven by the rising complexity of clinical trials, increasing R&D investments by pharmaceutical and biotech companies, and the need…
Femtech Market US$ 112.30 Billion by 2033 with 12.6% CAGR North America Leads wi …
The Global Femtech Market reached US$ 38.90 billion in 2024 and is projected to grow significantly to US$ 112.30 billion by 2033, registering a CAGR of 12.6% during the forecast period 2025-2033. This strong growth reflects increasing awareness of women's health issues, rising digital health adoption, and greater investments in technology-driven healthcare solutions tailored specifically for women.
Femtech focuses on addressing both female-specific and women-prevalent health conditions through products such as…
Precision Viticulture Market | US$ 9.51 Billion by 2032 | 14.40% CAGR | Europe L …
The Global Precision Viticulture Market reached US$ 3.24 billion in 2024 and is expected to reach US$ 9.51 billion by 2032, growing at a CAGR of 14.40% during the forecast period 2025-2032. Market growth is driven by the increasing adoption of advanced agricultural technologies to improve vineyard productivity, optimize resource utilization, and enhance grape quality amid rising climate variability.
Precision viticulture integrates technologies such as GPS, remote sensing, drones, IoT sensors,…
United States Public Safety and Security Market sees strong growth at a CAGR of …
The public safety and security market is projected to grow from USD 564.05 billion in 2025 to USD 979.84 billion by 2030 at a compound annual growth rate (CAGR) of 11.4% during the forecast period. The growing trend of IoT in public safety is driving the market as connected devices enable real-time monitoring, faster responses, and better management of emergencies. It helps authorities gather accurate data and improve decision-making. The…
More Releases for Diagnostics
Covid-19 Diagnostic Market is Booming Worldwide By Top Key Players: Abbott Diagn …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Covid-19 Diagnostic market. Players can use the accurate…
What are the Growth Drivers of Covid-19 Diagnostic Market? BD Diagnostics, Abbot …
Market Study Report LLC recently added a new title on 2020-2025 Global Covid-19 Diagnostic Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2025.
The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact…
North America Autoimmune Disease Diagnostics Market (2020-2026) | Abbott Laborat …
According to the Graphical Research new growth forecast report titled "North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Industry Analysis Report, Regional Outlook (U.S., Canada)", Estimated To Exceed USD 6.5 Billion By 2026. Autoimmune diagnostic procedures have increased demand for instruments and services for rapid and effective outcomes. Rising adoption of lab automation technology will foster…
Covid-19 Diagnostic Market Overall Study Report 2020-2026 | Abbott Diagnostics, …
This report focuses on Covid-19 Diagnostic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Covid-19 Diagnostic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Get Free Sample PDF Copy at https://www.reportsnreports.com/contacts/requestsample.aspx?name=3095138.
Top Key Players in the Global Covid-19 Diagnostic Market Include: -
o Abbott Diagnostics
o …
Global Allergy Diagnostics Market 2020 Lincoln Diagnostics, Hitachi Chemical Dia …
Global Allergy Diagnostics Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments
The research report on the global Allergy Diagnostics market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer…
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report.
Get Sample Copy of this Report @…
